Biotechs and Related Hitting 52-Week Lows Too (BBH, AMGN, AMLN, ARNA, GERN, INGN, PGNX, SUPG)

Print Email

Today has been a rough day with more 52-week lows than we can recall in quite some time.  The biotechs haven’t been immune.  You can even see that the Biotech HOLDRs (BBH) at $160+ are only about 2% above the 52-week lows of $157.95, while the iShares Nasdaq Biotechnology (IBB) ETF at $80.29 is only about half-way in its 52-week trading range of $72.37 to $89.00.  The difference is because of the composition.

Here are BIOTECH STOCKS hitting 52-week lows today:

  • Amgen (AMGN)
  • Amylin Pharma (AMLN)
  • Arena Pharma (ARNA)
  • Cleveland Biolabs (CBLI)
  • Geron (GERN)
  • Introgen (INGN)
  • Progenics Pharma (PGNX)
  • Somaxon Pharma (SOMX)
  • Spectrum Pharma (SPPI)
  • Supergen (SUPG)

If you wantto see how bad today is look at the master list of 52-week lows we compiled two hours ago with financials, restaurants, retail, REIT, property, tech and more.  It’s a huge list.

Jon C. Ogg
January 4, 2008